Cited by 143Crystallography and molecular interactionsComputational Drug Discovery MethodsAdvanced Chemical Physics Studies

Computational tools to model halogen bonds in medicinal chemistry.

Ford, Melissa Coates, Ho, P. Shing·2016·Journal of Medicinal Chemistry

Abstract

The use of halogens in therapeutics dates back to the earliest days of medicine when seaweed was used as a source of iodine to treat goiters. The incorporation of halogens to improve the potency of drugs is now fairly standard in medicinal chemistry. In the past decade, halogens have been recognized as direct participants in defining the affinity of inhibitors through a noncovalent interaction called the halogen bond or X-bond. Incorporating X-bonding into structure-based drug design requires computational models for the anisotropic distribution of charge and the nonspherical shape of halogens, which lead to their highly directional geometries and stabilizing energies. We review here current successes and challenges in developing computational methods to introduce X-bonding into lead compound discovery and optimization during drug development. This fast-growing field will push further development of more accurate and efficient computational tools to accelerate the exploitation of halogens in medicinal chemistry.

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.5b00997

Cites

116 of 116 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ford, M. C., & Ho, P. S.
Affiliations
Colorado State University (US)
Corresponding author
Ho, P. Shing
Venue
Journal of Medicinal Chemistry
Published
2015-10-21
Volume
59
Issue
5
Pages
1655-1670
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2415942953
Cited by
143
References
116
Citations by year
2026: 8 · 2025: 9 · 2024: 11 · 2023: 7 · 2022: 10 · 2021: 12 · 2020: 12 · 2019: 20 · 2018: 17 · 2017: 23 · 2016: 14
FWCI
1.14
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Division of Chemistry (CHE-1152494)
  • Colorado State University
Topics
  • Physical Sciences › Chemistry › Physical and Theoretical Chemistry › Crystallography and molecular interactions
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Physics and Astronomy › Atomic and Molecular Physics, and Optics › Advanced Chemical Physics Studies
Keywords
halogen bonding, structure-based drug design, non-covalent interactions, lead optimization
MeSH terms
Chemistry, Pharmaceutical, Halogens, Humans, Models, Molecular, Quantum Theory, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review